Lantiseptic® Skin Protectant, with its superior moisture barrier, has been tested in the laboratory, dermatologically and clinically. It has been found non-irritating, non-sensitizing, non-toxic and non-cytoxic. Lantiseptic has demonstrated its usefulness in protocols to reduce stage II and I skin breakdown and in maintaining skin integrity. Clinical trials have primarily involved nursing home residents.(For case histories click here.) Patients had either pre-exsisting skin breakdown or were at risk for breakdown from conditions such as incontinence, immobility or chronic illness. Lantiseptic® Skin Protectant often resulted in complete healing or significant improvement in as little as three weeks. Many cases of reddened skin cleared over night.